Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 2,114.30 | 1,887.48 | 1,682.30 | 1,411.45 |
| Operating Revenue | - | 2,114.30 | 1,887.48 | 1,682.30 | 1,411.45 |
| Cost Of Revenue | - | 912 | 798.95 | 679.52 | 578.50 |
| Gross Profit | - | 1,202.30 | 1,088.53 | 1,002.77 | 832.95 |
| Operating Expense | - | 1,134.42 | 1,049.86 | 961.84 | 828.85 |
| Research And Development | - | 61.52 | 55.80 | 45.26 | 33.94 |
| Selling General And Administration | - | 1,072.90 | 994.06 | 916.58 | 794.90 |
| Total Expenses | - | 2,046.42 | 1,848.81 | 1,641.36 | 1,407.34 |
| Operating Income | - | 67.88 | 38.67 | 40.94 | 4.11 |
| Total Operating Income As Reported | - | 67.88 | 22.94 | 22.87 | -46.59 |
| EBITDA | - | 135.28 | 96.98 | 89.22 | 9.02 |
| Normalized EBITDA | - | 135.28 | 112.71 | 107.29 | 59.71 |
| EBIT | - | 67.88 | 22.94 | 22.87 | -46.59 |
| Interest Expense | - | 18.98 | 42.70 | 48.37 | 49.38 |
| Net Interest Income | - | -18.98 | -42.70 | -48.37 | -49.38 |
| Other Income Expense | - | - | -15.73 | -18.07 | -50.70 |
| Interest Expense Non Operating | - | 18.98 | 42.70 | 48.37 | 49.38 |
| Net Non Operating Interest Income Expense | - | -18.98 | -42.70 | -48.37 | -49.38 |
| Pretax Income | - | 48.90 | -19.75 | -25.50 | -95.97 |
| Tax Provision | - | 12.28 | -4.47 | -5.16 | 35.98 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 0 | -3.56 | -3.65 | -20.28 |
| Net Income Continuous Operations | - | 36.61 | -15.29 | -20.33 | -131.96 |
| Net Income From Continuing And Discontinued Operation | - | 36.61 | -15.29 | -20.33 | -131.96 |
| Net Income From Continuing Operation Net Minority Interest | - | 36.61 | -15.29 | -20.33 | -131.96 |
| Net Income | - | 36.61 | -15.29 | -20.33 | -131.96 |
| Net Income Common Stockholders | - | 36.61 | -15.29 | -20.33 | -131.96 |
| Net Income Including Noncontrolling Interests | - | 36.61 | -15.29 | -20.33 | -131.96 |
| Normalized Income | - | 36.61 | -3.11 | -5.92 | -101.54 |
| Diluted NI Availto Com Stockholders | - | 36.61 | -15.29 | -20.33 | -131.96 |
| Basic Average Shares | - | 22.40 | 22.43 | 22.61 | 22.88 |
| Diluted Average Shares | - | 22.85 | 22.43 | 22.61 | 22.88 |
| Reconciled Depreciation | - | 67.40 | 74.04 | 66.35 | 55.61 |
| Reconciled Cost Of Revenue | - | 912 | 798.95 | 679.52 | 578.50 |
| Total Unusual Items | - | 0 | -15.73 | -18.07 | -50.70 |
| Total Unusual Items Excluding Goodwill | - | 0 | -15.73 | -18.07 | -50.70 |
| Special Income Charges | - | 0 | -15.73 | -18.07 | -50.70 |
| Restructuring And Mergern Acquisition | - | 0 | 15.73 | 18.07 | 50.70 |
| General And Administrative Expense | - | 153.27 | 146.62 | 149.96 | 130.67 |
| Other Gand A | - | 153.27 | 146.62 | 149.96 | 130.67 |
| Selling And Marketing Expense | - | 919.63 | 847.44 | 766.62 | 664.24 |
